S&P 500   4,637.99 (-0.37%)
DOW   34,890.76 (-0.70%)
QQQ   400.33 (+0.16%)
AAPL   162.99 (+1.72%)
MSFT   336.11 (-0.15%)
FB   335.49 (-0.75%)
GOOGL   2,918.37 (+0.27%)
AMZN   3,578.49 (+0.48%)
TSLA   1,163.12 (+2.30%)
NVDA   331.68 (-0.62%)
BABA   129.97 (-1.25%)
NIO   41.05 (+1.46%)
CGC   10.92 (-1.27%)
AMD   163.54 (+1.01%)
GE   96.45 (-1.98%)
MU   86.33 (+0.22%)
T   23.19 (-2.93%)
F   19.56 (-0.56%)
DIS   146.40 (-0.95%)
ACB   6.44 (+0.00%)
AMC   35.70 (-3.09%)
PFE   53.19 (+1.51%)
BA   196.31 (-1.10%)
S&P 500   4,637.99 (-0.37%)
DOW   34,890.76 (-0.70%)
QQQ   400.33 (+0.16%)
AAPL   162.99 (+1.72%)
MSFT   336.11 (-0.15%)
FB   335.49 (-0.75%)
GOOGL   2,918.37 (+0.27%)
AMZN   3,578.49 (+0.48%)
TSLA   1,163.12 (+2.30%)
NVDA   331.68 (-0.62%)
BABA   129.97 (-1.25%)
NIO   41.05 (+1.46%)
CGC   10.92 (-1.27%)
AMD   163.54 (+1.01%)
GE   96.45 (-1.98%)
MU   86.33 (+0.22%)
T   23.19 (-2.93%)
F   19.56 (-0.56%)
DIS   146.40 (-0.95%)
ACB   6.44 (+0.00%)
AMC   35.70 (-3.09%)
PFE   53.19 (+1.51%)
BA   196.31 (-1.10%)
S&P 500   4,637.99 (-0.37%)
DOW   34,890.76 (-0.70%)
QQQ   400.33 (+0.16%)
AAPL   162.99 (+1.72%)
MSFT   336.11 (-0.15%)
FB   335.49 (-0.75%)
GOOGL   2,918.37 (+0.27%)
AMZN   3,578.49 (+0.48%)
TSLA   1,163.12 (+2.30%)
NVDA   331.68 (-0.62%)
BABA   129.97 (-1.25%)
NIO   41.05 (+1.46%)
CGC   10.92 (-1.27%)
AMD   163.54 (+1.01%)
GE   96.45 (-1.98%)
MU   86.33 (+0.22%)
T   23.19 (-2.93%)
F   19.56 (-0.56%)
DIS   146.40 (-0.95%)
ACB   6.44 (+0.00%)
AMC   35.70 (-3.09%)
PFE   53.19 (+1.51%)
BA   196.31 (-1.10%)
S&P 500   4,637.99 (-0.37%)
DOW   34,890.76 (-0.70%)
QQQ   400.33 (+0.16%)
AAPL   162.99 (+1.72%)
MSFT   336.11 (-0.15%)
FB   335.49 (-0.75%)
GOOGL   2,918.37 (+0.27%)
AMZN   3,578.49 (+0.48%)
TSLA   1,163.12 (+2.30%)
NVDA   331.68 (-0.62%)
BABA   129.97 (-1.25%)
NIO   41.05 (+1.46%)
CGC   10.92 (-1.27%)
AMD   163.54 (+1.01%)
GE   96.45 (-1.98%)
MU   86.33 (+0.22%)
T   23.19 (-2.93%)
F   19.56 (-0.56%)
DIS   146.40 (-0.95%)
ACB   6.44 (+0.00%)
AMC   35.70 (-3.09%)
PFE   53.19 (+1.51%)
BA   196.31 (-1.10%)
NASDAQ:BJDX

Bluejay Diagnostics Stock Forecast, Price & News

$3.12
-0.22 (-6.59%)
(As of 11/30/2021 10:02 AM ET)
Add
Compare
Today's Range
$3.12
$3.38
50-Day Range
N/A
52-Week Range
$2.65
$6.25
Volume
261 shs
Average Volume
1.85 million shs
Market Capitalization
$39.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BJDX News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.


About Bluejay Diagnostics

Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BJDX
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$39.59 million
Optionable
Not Optionable

Company Calendar

Today
11/30/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1390th out of 1,390 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Bluejay Diagnostics (NASDAQ:BJDX) Frequently Asked Questions

When did Bluejay Diagnostics IPO?

(BJDX) raised $22 million in an initial public offering on Wednesday, November 10th 2021. The company issued 2,160,000 shares at $10.00 per share.

What is Bluejay Diagnostics' stock symbol?

Bluejay Diagnostics trades on the NASDAQ under the ticker symbol "BJDX."

When does Bluejay Diagnostics' quiet period expire?

Bluejay Diagnostics' quiet period expires on Monday, December 20th. Bluejay Diagnostics had issued 2,160,000 shares in its public offering on November 10th. The total size of the offering was $21,600,000 based on an initial share price of $10.00. During Bluejay Diagnostics' quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Bluejay Diagnostics?

Shares of BJDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bluejay Diagnostics' stock price today?

One share of BJDX stock can currently be purchased for approximately $3.12.

How much money does Bluejay Diagnostics make?

Bluejay Diagnostics has a market capitalization of $39.59 million.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.